Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Upper Respiratory Tract Infection Workup

  • Author: Anne Meneghetti, MD; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
 
Updated: Jun 06, 2016
 

Approach Considerations

In upper respiratory tract infections (URIs), tests for specific pathogens are helpful when targeted therapy depends on the results (eg, group A streptococcal infection, gonococcus, pertussis). Specific bacterial or viral testing is also warranted in other selected situations, such as when patients are immunocompromised, during certain outbreaks, or to provide specific therapy to contacts. There is insufficient evidence that testing for atypical bacteria (eg, Chlamydia pneumoniae, Mycoplasma pneumoniae) would improve clinical outcomes in pharyngitis.[33]

Targeted therapy is not available for most viruses that cause URI. Therefore, viral testing is rarely indicated for uncomplicated viral URIs in the outpatient setting. However, confirmation of a viral condition such as influenza may reduce inappropriate use of antibiotics. In addition, URI suspected to be due to herpes simplex virus (HSV) warrants diagnosis because specific therapy is available for this infection.

Testing may be required if progressive URI symptoms last longer than 14 days and have no other identifiable cause, such as asthma or allergic rhinitis. Testing is also indicated if the clinical assessment suggests sexually transmitted disease–related oropharyngeal disease; specific therapy exists for pathogens such as Neisseria gonorrhoeae.

With immunocompromised patients, specific information about infection may help to tailor antimicrobial choices, herald potential complications, and aid in determining whether hospitalization would be appropriate. Viral testing may be used for making the diagnosis, monitoring the patient, or predicting the prognosis.

Nasopharyngeal sampling

Culturing of throat swabs, nasal swabs or washes, or nasal aspirates remains the standard for confirming bacterial URI pathogens. Samples should be taken from the posterior pharynx or tonsils, not from the oral cavity. In typical circumstances, rapid antigen detection tests for group A strep need not be routinely backed up by cultures in adults.[2]

For pharyngitis, a throat swab may be performed by vigorously rubbing a dry swab over the posterior pharynx and both tonsils to obtain a sample of exudates, if any exist. Avoid touching other surfaces of the oropharynx. Samples should be transported dry.

To perform a nasal wash, fill a small syringe (3-5 mL) with sodium chloride solution and attach a short length of flexible tubing. With the patient's head tilted back, instill the solution rapidly into the nostril, then immediately aspirate secretions back into the syringe and transfer the aspirate to laboratory specimen containers.

Nasopharyngeal specimens are indicated for suspected pertussis; the sample can be used for culture and for polymerase chain reaction (PCR) assay.[34] Special selective growth media are required for Corynebacterium diphtheriae. This organism must be distinguished from the diphtheroids that commonly inhabit the nasopharynx. Neisseria gonorrhoeae also requires special culture media.

For confirming viral nasopharyngeal infection, viral cultures remain the standard. Throat swabs, nasal swabs or washes, or sputum may be cultured on special viral media to detect influenza virus, parainfluenza virus (PIV), adenovirus, respiratory syncytial virus (RSV), and other viruses. Culturing may require days to weeks.

Rapid tests for viruses include various antigen, immunofluorescence, and PCR assays. Rapid tests for influenza can be conducted on specimens from nasopharyngeal swabs, washes, or aspirates, yielding results within 30 minutes. Swabs should be taken from the posterior pharynx or tonsils, not from the oropharynx.

Enzyme immunoassays are available to detect PIV in respiratory secretions. Reverse transcriptase PCR assay may detect various viruses in nasopharyngeal samples. PCR assay detection of various viruses from blood samples is emerging as a way to track certain viral infections.

Antibody titers compared between paired specimens obtained weeks apart may help in retrospectively identifying a particular pathogen in immunocompetent patients. The first sample should be obtained during the first week of illness, and the second should be obtained 2-4 weeks later.

Blood count and cultures

On complete blood count (CBC) with differential, patients with URIs may have an increased white blood cell (WBC) count with a left shift. Atypical lymphocytes, lymphocytosis, or lymphopenia may be seen in some viral infections; lymphocytosis may also be seen in pertussis.

However, a CBC is not likely to be helpful in differentiating the infectious agent or in directing therapy in uncomplicated URIs in the outpatient setting. Blood cultures are typically appropriate only in hospitalized patients with suspected systemic illness.

Imaging studies

Imaging studies are not indicated for the common cold. On the other hand, suspected mass lesions, such as a peritonsillar abscess or intracranial suppurative lesions, warrant imaging. If the patient's history and physical findings suggest lower respiratory tract disease, chest imaging may be useful. Similarly, routine acute rhinosinusitis (ie, during the first weeks of symptoms) does not require imaging unless suppurative complications or structural anomalies are suspected. In laryngitis, radiographs are of little use except to exclude foreign-body aspiration.

Laryngotracheitis in a patient with typical symptoms that respond appropriately to treatment does not require imaging. Laryngoscopy may be considered, however, if the patient is not in extremis. Hemoptysis or the presence of risk factors for tuberculosis should prompt consideration for tuberculin testing and chest radiography.

In laryngotracheobronchitis (croup), soft-tissue neck images may reveal the classic steeple sign, which represents subglottic narrowing. However, this sign is not always present and is not specific for croup.

Suspected Group A Streptococcal Infection

The diagnosis should be pursued on the basis of clinical findings or a history of exposure to a case, supported by results of rapid-detection assays and cultures. Patients with a personal history of rheumatic fever or a household contact with a history of rheumatic fever are at high risk for group A streptococcal infection. In addition, the following features may raise suspicion for group A streptococcal disease[1] :

  • Erythema, swelling, or exudates of tonsils or pharynx
  • Fever with a temperature of at least 38.3°C (100.9°F) in the preceding 24 hours
  • Tender anterior cervical lymph nodes (1 cm or larger)
  • Absence of cough, rhinorrhea, and conjunctivitis (these are common in viral illness)
  • Patient aged 5-15 years
  • Occurrence in the season with highest prevalence (ie, November to May)
  • Local case trends

The 2012 Infectious Diseases Society of America (IDSA) guidelines recommend that swabbing the throat and testing for group A streptococcal pharyngitis by rapid antigen detection testing, culture, or both should be performed to diagnose group A streptococcal pharyngitis.[2] The rationale is that clinical features alone do not reliably discriminate between streptococcal and viral pharyngitis, except when overt viral features (eg, rhinorrhea, cough, oral ulcers, and/or hoarseness) are present.

The IDSA guidelines also suggest that diagnostic studies for group A streptococcal pharyngitis are not indicated in children under age 3 years, as acute rheumatic fever and a classic presentation of strep throat are uncommon in this age group. However, selected children under age 3 years who have other risk factors (eg, an older sibling with known infection) may be considered for testing.[2]

Positive rapid antigen detection tests are highly specific and therefore do not necessitate a backup culture. Negative tests should be backed up by a throat culture in children and adolescents. Routine backup throat culture for adults with a negative rapid strep test is not typically necessary, due to the low incidence of streptococcal pharyngitis in adults and the low risk of subsequent acute rheumatic fever. Testing of asymptomatic household contacts of patients with acute streptococcal pharyngitis is not routinely recommended.[2]

Cultures may be falsely negative for group A streptococci, because of inadequate specimen collection, covert use of antibiotics, or suboptimal laboratory practices. In addition, prolonged illness may reduce the sensitivity of culture. Specimens are optimally obtained in the first 4 days of illness. Some patients may be chronically colonized with group A streptococcus.

The level of streptococcal antibodies (antistreptolysin O) does not peak until 4-5 weeks after the onset of pharyngitis. Therefore, testing for these antibodies has no role in the diagnosis of acute pharyngitis.

Next

Suspected Acute Bacterial Rhinosinusitis

Laboratory studies are generally not indicated in cases of suspected acute bacterial rhinosinusitis, because the causative agents in immunocompetent individuals are well characterized.[7] (See Acute Sinusitis.)

Imaging studies

Computed tomography scanning

Imaging studies are not indicated for routine acute rhinosinusitis (ie, during the first 4 weeks of symptoms). A negative study may be helpful in ruling out rhinosinusitis, but imaging studies do not help in distinguishing bacterial from viral disease, because no diagnostic signs are unique to bacterial sinus infection. Moreover, although sinus CT scanning is highly sensitive, its specificity for demonstrating acute sinusitis is low; 40% of asymptomatic patients and 87% of those with common colds have sinus abnormalities.[16]

In children, the lack of fully developed sinuses poses challenges in image interpretation. The frontal sinuses do not typically appear until age 5-8 years, and they may not develop fully in all individuals.

If rhinosinusitis symptoms persist despite therapy or if complications (eg, extension of disease into surrounding tissue) are suspected, sinus imaging may be appropriate to evaluate the anatomy. Signs or symptoms consistent with intracranial extension of infection warrant CT scanning to evaluate the possibility of an intracranial abscess or other suppurative complication. Such symptoms may include the following:

  • Proptosis
  • Impaired intraocular movements
  • Decreased vision
  • Papilledema
  • Changes in mental status
  • Other neurologic findings

CT scanning yields more detailed information than plain radiography, especially regarding the ostiomeatal complex. Such information may be relevant to surgical planning. Common CT scan findings include mucosal thickening, air-fluid levels, and obstruction of the ostiomeatal complex. Not all patients with acute rhinosinusitis have air-fluid levels. The image below reveals sinusitis on a CT scan.

CT scan of the sinuses demonstrates maxillary sinu CT scan of the sinuses demonstrates maxillary sinusitis. The left maxillary sinus is completely opacified (asterisk), and the right has mucosal thickening (arrow). Courtesy of Omar Lababede, MD, Cleveland Clinic Foundation.

Other imaging studies

If a patient cannot tolerate CT scanning, a plain radiographic Waters view of the frontal and maxillary sinuses may be considered. Most cases of rhinosinusitis involve the maxillary and frontal sinuses, so views that include these sinuses are important. Common radiographic findings include air-fluid levels and mucosal thickening, although not all sinusitis patients have air-fluid levels.

Sinus ultrasonography may be considered when pregnancy or radiation exposure is a concern. Ultrasonography may also be useful in the intensive care unit to evaluate nosocomial sinusitis.[35] Magnetic resonance imaging (MRI) may be optimal for evaluation of suspected fungal sinusitis or suspected tumor.

Sinus puncture and aspiration

The sinus puncture and aspiration procedure has no role in the routine assessment of acute rhinosinusitis. However, maxillary sinus puncture and aspiration performed by an otolaryngologist may be indicated in patients with any of the following:

  • Complex and persistent disease
  • Suppurative extensions of disease
  • Serious immunocompromise
  • Nosocomial sinus infection

Rigid nasal endoscopy is a less robust option than sinus puncture because of specimen contamination by nasal flora. Respiratory flora also commonly contaminates nasal swabs and washes.

Suspected Influenza

In cases of suspected influenza, confirmation of a serotype-specific diagnosis may direct options for antiviral therapy. Testing may also assist the clinician in avoiding unnecessary prescriptions for antibacterials. Most rapid tests to detect influenza that are performed in a physician's office have a sensitivity of approximately greater than 70% and a specificity of approximately greater than 90%. Therefore, viral culture may yield a positive result in up to 30% of cases with negative rapid influenza test results.[27]

For information on testing and case management of suspected influenza, see the Medscape Reference article Influenza.

Previous
Next

Suspected Mononucleosis

In a person with sore throat, lymphadenopathy, and hepatosplenomegaly, testing may be required to confirm infectious mononucleosis. Confirmation may be helpful in guiding outpatient care and expectations. A positive result on a heterophile antibody test (eg, Monospot) is diagnostic.

Heterophile antibody levels are moderate to high in the first month of illness and decrease rapidly thereafter. Monospot results are positive in more than 85% of cases. False-positive results are seen in a few patients; false-negative results are seen in 10-15% of patients, primarily children younger than 10 years.[23]

Previous
Next

Suspected Herpes Simplex Virus Infection

In patients with mucocutaneous lesions suggestive of HSV infection, isolation of the virus in cell culture is the preferred virologic testing strategy. As lesions begin to heal, the sensitivity of culturing rapidly declines. Cytologic detection of cellular changes of HSV infection is insensitive and nonspecific and should not be relied on for diagnosis of HSV infection.[36] Testing with polymerase chain reaction (PCR) assay is available in some laboratories.

Previous
Next

Suspected Pertussis

Pertussis is clinically diagnosed on the basis of symptoms of whooping cough. When bacteriologic confirmation is sought, the receiving laboratory should be contacted for special instructions on specimen collection. Culture of a nasopharyngeal aspirate is the criterion standard.[37] Nasopharyngeal aspirates are ideally collected 0-2 weeks after symptom onset but may provide accurate results for as long as 4 weeks in infants and unvaccinated patients.

Rapid direct fluorescent antibody testing is available to test for pertussis. Although PCR assay for pertussis is emerging as a sensitive detection tool, respiratory illness outbreaks mistakenly attributed to pertussis highlight the limitations of relying solely on PCR assays to confirm the disease. The positive predictive value is lower when PCR assay is used as a screening tool without culture confirmation during a suspected pertussis outbreak.[21]

Serologic testing is optimally performed 2-8 weeks after symptom onset, when antibody titers are highest. However, testing may be performed on specimens as long as 12 weeks after symptom onset.

Previous
Next

Suspected Epiglottitis

In cases of suspected epiglottitis, aggressive instrumentation may precipitate spasm and airway compromise. If the diagnosis is suspected in patients not in extremis, an otorhinolaryngologist may perform direct visualization by laryngoscope to confirm the disease. Immediate access to intubation and cricothyroidotomy equipment is required. This diagnostic procedure is often performed in the operating room.

Laryngoscopy provides an opportunity for obtaining culture samples; however, contamination of the samples by upper airway flora is common. Direct visualization by laryngoscope is the standard for confirming epiglottitis.

During the procedure, a swab sample may be taken for culturing. However, because of contamination with upper airway flora, such cultures are not ideal unless an aspirate is taken from an epiglottic abscess. Therefore, blood cultures should also be ordered. Blood cultures for Haemophilus influenzae are positive in more than 80% of children and in approximately 25% of adults.[38]

Before ordering radiography, consider whether imaging may unnecessarily delay patient care. Note that patients with epiglottitis breathe most comfortably when they are upright; the supine position may precipitate respiratory compromise. For patients in whom the diagnosis of epiglottitis is uncertain, a lateral neck image obtained in the erect position with soft-tissue technique may be indicated.

In one small, retrospective study, lateral neck radiographs were 33% specific for epiglottitis, with a positive predictive value of only 50%; the negative predictive value was 100%.[39] Given the high false-positive rate, the authors concluded that the role of radiography was limited in epiglottitis. However, neck imaging may help to rule out the disease. Radiographic findings include a swollen epiglottis with a shape similar to the human thumb. The image below illustrates epiglottitis on a neck radiograph.

Lateral neck radiograph demonstrates epiglottitis. Lateral neck radiograph demonstrates epiglottitis. Courtesy of Marilyn Goske, MD, Cleveland Clinic Foundation.

CT scanning may be superior to radiography in delineating the soft-tissue structures in the upper airway. However, CT scanning may unnecessarily delay therapy, and recumbent positioning may precipitate respiratory compromise.

Previous
 
 
Contributor Information and Disclosures
Author

Anne Meneghetti, MD Assistant Professor of Medicine, Tufts University School of Medicine; Medical Broadcaster, MyWell-Being.com

Anne Meneghetti, MD is a member of the following medical societies: National Ayurvedic Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD, FACP, FCCP Geri and Richard Brawerman Chair in Pulmonary and Critical Care Medicine, Professor and Executive Vice Chairman, Department of Medicine, Medical Director, Women's Guild Lung Institute, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

Zab Mosenifar, MD, FACP, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Thoracic Society

Disclosure: Nothing to disclose.

Acknowledgements

Gregory William Rutecki, MD Professor of Medicine, Fellow of The Center for Bioethics and Human Dignity, University of South Alabama College of Medicine

Gregory William Rutecki, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Society of Nephrology, National Kidney Foundation, and Society of General Internal Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. [Guideline] Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis. 1997 Sep. 25(3):574-83. [Medline].

  2. [Guideline] Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15. 55(10):1279-82. [Medline]. [Full Text].

  3. [Guideline] Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, Marcy SM, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013 Jul. 132(1):e262-80. [Medline].

  4. Utah Department of Health, Bureau of Epidemiology. Whooping Cough Sound Files. Utah Department of Health, Bureau of Epidemiology. Available at http://health.utah.gov/epi/diseases/pertussis/pertussis_sounds.htm. Accessed: November 29, 2012.

  5. Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Clinical Features. Available at http://www.cdc.gov/pertussis/clinical/features.html. Accessed: October 27, 2013.

  6. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, Varonen H, Rautakorpi UM, Williams JW Jr, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2008 Apr 16. CD000243. [Medline].

  7. [Guideline] Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012 Apr. 54(8):e72-e112. [Medline]. [Full Text].

  8. Chung LP, Waterer GW. Genetic predisposition to respiratory infection and sepsis. Crit Rev Clin Lab Sci. 2011 Sep-Dec. 48(5-6):250-68. [Medline].

  9. Horby P, Nguyen NY, Dunstan SJ, Baillie JK. The role of host genetics in susceptibility to influenza: a systematic review. PLoS One. 2012. 7(3):e33180. [Medline]. [Full Text].

  10. Juno J, Fowke KR, Keynan Y. Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. Clin Dev Immunol. 2012. 2012:797180. [Medline]. [Full Text].

  11. Meriluoto M, Hedman L, Tanner L, Simell V, Mäkinen M, Simell S, et al. Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis. 2012 Feb. 18(2):264-71. [Medline]. [Full Text].

  12. National Center for Infectious Diseases. Division of Bacterial and Mycotic Diseases. Haemophilus influenzae serotype b (Hib) disease. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/hi-disease/clinicians.html. Accessed: November 29, 2012.

  13. National Center for Infectious Diseases. Respiratory and Enteric Viruses Branch. Human parainfluenza viruses (HPIVs). Centers for Disease Control and Prevention. Available at http://www.cdc.gov/ncidod/dvrd/revb/respiratory/hpivfeat.htm. Accessed: April 30, 2009.

  14. [Guideline] Schwartz SR, Cohen SM, Dailey SH, et al. Clinical practice guideline: hoarseness (dysphonia). Otolaryngol Head Neck Surg. 2009 Sep. 141(3 Suppl 2):S1-S31. [Full Text].

  15. Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2006 Summary. 2008. Available at http://www.cdc.gov/nchs/data/nhsr/nhsr003.pdf.

  16. Fagnan LJ. Acute sinusitis: a cost-effective approach to diagnosis and treatment. Am Fam Physician. 1998 Nov 15. 58(8):1795-802, 805-6. [Medline].

  17. Centers for Disease Control and Prevention. Accessed April 30, 2009. Nonspecific upper respiratory tract infection. Available at http://www.cdc.gov/drugresistance/community/hcp-info-sheets/adult-nurti.pdf.

  18. Isakson M, Hugosson S. Acute epiglottitis: epidemiology and Streptococcus pneumoniae serotype distribution in adults. J Laryngol Otol. 2011 Apr. 125(4):390-3. [Medline].

  19. Centers for Disease Control and Prevention. Pertussis (Whooping Cough) Surveillance & Reporting. Available at http://www.cdc.gov/pertussis/surv-reporting.html. Accessed: June 12, 2012.

  20. Bettiol S, Wang K, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev. 2012 May 16. 5:CD003257. [Medline].

  21. Centers for Disease Control and Prevention. Outbreaks of respiratory illness mistakenly attributed to pertussis--New Hampshire, Massachusetts, and Tennessee, 2004-2006. MMWR Morb Mortal Wkly Rep. 2007 Aug 24. 56(33):837-42. [Medline]. [Full Text].

  22. CDC Centers for Disease Control and Prevention. Seasonal Influenza (Flu). Centers for Disease Control and Prevention. Available at http://www.cdc.gov/flu/about/disease/index.htm. Accessed: June 12, 2012.

  23. National Center for Infectious Diseases. Division of Bacterial and Mycotic Diseases. Epstein-Barr virus and infectious mononucleosis. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/ncidod/diseases/ebv.htm. Accessed: April 30, 2009.

  24. Centers for Disease Control and Prevention. CDC. Diphtheria. Centers for Disease Control and Prevention. CDC.gov. Available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/diptheria_t.htm. Accessed: June 12, 2012.

  25. National Institute of Allergy and Infectious Diseases. Common Cold. National Institute of Allergy and Infectious Diseases. Available at http://www.niaid.nih.gov/topics/commoncold/Pages/default.aspx. Accessed: June 12, 2012.

  26. Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. 1991 Feb. 87(2):129-33. [Medline].

  27. CDC. Centers for Disease Control and Prevention. Seasonal Influenza (Flu): Seasonal Influenza-Associated Hospitalizations in the United States. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/flu/about/qa/hospital.htm. Accessed: November 29, 2012.

  28. CDC. Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Clinical Complications. Available at http://www.cdc.gov/pertussis/clinical/complications.html. Accessed: June 12, 2012.

  29. Arola M, Ruuskanen O, Ziegler T, Mertsola J, Näntö-Salonen K, Putto-Laurila A, et al. Clinical role of respiratory virus infection in acute otitis media. Pediatrics. 1990 Dec. 86(6):848-55. [Medline].

  30. Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update. Curr Opin Pediatr. 2009 Feb. 21(1):127-30. [Medline].

  31. National Institute of Allergy and Infectious Diseases. Common Cold: Symptoms. Available at http://www.niaid.nih.gov/topics/commonCold/Pages/symptoms.aspx. Accessed: October 17, 2013.

  32. [Guideline] Division of STD Prevention, CDC. Gonococcal Infections. Sexually Transmitted Diseases Treatment Guidelines, 2010. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/std/treatment/2010/gonococcal-infections.htm. Accessed: November 29, 2012.

  33. Vincent MT, Celestin N, Hussain AN. Pharyngitis. Am Fam Physician. 2004 Mar 15. 69(6):1465-70. [Medline].

  34. CDC. Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Specimen Collection. Full text: http://cid.oxfordjournals.org/content/early/2012/09/06/cid.cis629.full. Available at http://www.cdc.gov/pertussis/clinical/diagnostic-testing/specimen-collection.html. Accessed: October 17, 2013.

  35. Chow AW. Acute sinusitis: current status of etiologies, diagnosis, and treatment. Curr Clin Top Infect Dis. 2001. 21:31-63. [Medline].

  36. [Guideline] Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006 Aug 4. 55:1-94. [Medline]. [Full Text].

  37. CDC. Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Diagnostic Testing. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/pertussis/clinical/diagnostic-testing/index.html. Accessed: November 29, 2012.

  38. Adult epiglottitis: best practice of medicine [Internet database]. April, 2000;

  39. Ragosta KG, Orr R, Detweiler MJ. Revisiting epiglottitis: a protocol--the value of lateral neck radiographs. J Am Osteopath Assoc. 1997 Apr. 97(4):227-9. [Medline].

  40. MacReady N. AAP Releases New Principles for URI Antibiotics. Medscape Medical News. Available at http://www.medscape.com/viewarticle/814533. Accessed: November 26, 2013.

  41. Hersh AL, Jackson MA, Hicks LA. Principles of Judicious Antibiotic Prescribing for Bacterial Upper Respiratory Tract Infections in Pediatrics. Pediatrics. 2013 Nov 18. [Medline].

  42. Little P, Moore M, Kelly J, et al. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ. 2014 Mar 6. 348:g1606. [Medline]. [Full Text].

  43. Kissoon N, Mitchell I. Adverse effects of racemic epinephrine in epiglottitis. Pediatr Emerg Care. 1985 Sep. 1(3):143-4. [Medline].

  44. Weber JE, Chudnofsky CR, Younger JG, Larkin GL, Boczar M, Wilkerson MD, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics. 2001 Jun. 107(6):E96. [Medline].

  45. [Guideline] Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan. 129(1 Suppl):1S-23S. [Medline].

  46. Update: influenza activity - United States, September 28, 2008--January 31, 2009. MMWR Morb Mortal Wkly Rep. 2009 Feb 13. 58(5):115-9. [Medline]. [Full Text].

  47. van den Aardweg MT, Boonacker CW, Rovers MM, Hoes AW, Schilder AG. Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomised controlled trial. BMJ. 2011 Sep 6. 343:d5154. [Medline]. [Full Text].

  48. Harvey R, Hannan SA, Badia L, Scadding G. Nasal irrigation with saline (salt water) for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. January 24, 2007. Issue 3:[Medline]. [Full Text].

  49. Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Fam Pract. 2002 Dec. 51(12):1049-55. [Medline]. [Full Text].

  50. Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, Berlin CM Jr. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med. 2007 Dec. 161(12):1140-6. [Medline]. [Full Text].

  51. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar--pediatric cough and cold medications. N Engl J Med. 2007 Dec 6. 357(23):2321-4. [Medline].

  52. Food and Drug Administration. FDA Statement Following CHPA's Announcement on Nonprescription Over-the-Counter Cough and Cold Medicines in Children. FDA: U.S. Food and Drug Administration. Available at http://www.fda.gov/bbs/topics/NEWS/2008/NEW01899.html. Accessed: May 10, 2009.

  53. Wiklund L, Stierna P, Berglund R, Westrin KM, Tonnesson M. The efficacy of oxymetazoline administered with a nasal bellows container and combined with oral phenoxymethyl-penicillin in the treatment of acute maxillary sinusitis. Acta Otolaryngol Suppl. 1994. 515:57-64. [Medline].

  54. Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996 Jul 15. 125(2):89-97. [Medline].

  55. Turner RB, Sperber SJ, Sorrentino JV, O'Connor RR, Rogers J, Batouli AR, et al. Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold. Clin Infect Dis. 1997 Oct. 25(4):824-30. [Medline].

  56. [Guideline] American Academy of Pediatrics. Clinical practice guideline: management of sinusitis. Pediatrics. 2001 Sep. 108(3):798-808. [Medline].

  57. Zalmanovici A, Yaphe J. Steroids for acute sinusitis. Cochrane Database Syst Rev. 2007 Apr 18. CD005149. [Medline].

  58. American Academy of Pediatrics. Use of codeine- and dextromethorphan-containing cough remedies in children. American Academy of Pediatrics. Committee on Drugs. Pediatrics. 1997 Jun. 99(6):918-20. [Medline].

  59. Wing A, Villa-Roel C, Yeh B, Eskin B, Buckingham J, Rowe BH. Effectiveness of corticosteroid treatment in acute pharyngitis: a systematic review of the literature. Acad Emerg Med. 2010 May. 17(5):476-83. [Medline].

  60. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial. Ear Nose Throat J. 2000 Oct. 79(10):778-80, 782. [Medline].

  61. United States Food and Drug Administration. Accessed June 16, 2009. Zicam cold remedy nasal products (Cold Remedy Nasal Gel, Cold Remedy Nasal Swabs, and Cold Remedy Saws, Kids Size). MedWatch Public Health Advisory. Available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166996.htm.

  62. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2011 Feb 16. 2:CD001364. [Medline].

  63. Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. 2003 Dec 3. 290(21):2824-30. [Medline].

  64. Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S, et al. Echinacea for treating the common cold: a randomized trial. Ann Intern Med. 2010 Dec 21. 153(12):769-77. [Medline].

  65. Brinckmann J, Sigwart H, van Houten Taylor L. Safety and efficacy of a traditional herbal medicine (Throat Coat) in symptomatic temporary relief of pain in patients with acute pharyngitis: a multicenter, prospective, randomized, double-blinded, placebo-controlled study. J Altern Complement Med. 2003 Apr. 9(2):285-98. [Medline].

  66. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ. 2002 Jun 8. 324(7350):1361. [Medline].

  67. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, et al. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev. 2011. 17:6-63. [Full Text].

  68. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006 Dec 15. 55:1-37. [Medline]. [Full Text].

  69. [Guideline] Workowski KA, Levine WC. Sexually transmitted diseases treatment guidelines: 2002 [Centers for Disease Control and Prevention Web site]. MMWR. 2002. 51(RR06):1-80. [Full Text].

  70. American Academy of Pediatrics. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics. 2006 Mar. 117(3):965-78. [Medline].

  71. [Guideline] Safer Healthier PeopleCenters for Disease Control and Prevention. Pertussis: Summary of Vaccine Recommendations. Safer Healthier People. Available at http://www.cdc.gov/vaccines/vpd-vac/pertussis/recs-summary.htm. Accessed: 02/10/2011.

 
Previous
Next
 
Seasonal variation of selected upper respiratory tract infection pathogens. PIV is parainfluenza virus, RSV is respiratory syncytial virus, MPV is metapneumovirus, and Group A Strept is group A streptococcal disease.
CT scan of the sinuses demonstrates maxillary sinusitis. The left maxillary sinus is completely opacified (asterisk), and the right has mucosal thickening (arrow). Courtesy of Omar Lababede, MD, Cleveland Clinic Foundation.
Lateral neck radiograph demonstrates epiglottitis. Courtesy of Marilyn Goske, MD, Cleveland Clinic Foundation.
Gonococcal pharyngitis. Image credit: CDC Public Health Image Library (Flumara NJ, Hart G).
Strep throat with petechiae. CDC Public Health Image Library (Eichenwald HF).
Table. Symptoms of Allergies, URIs, and Influenza
Symptom Allergy URI Influenza
Itchy, watery eyes Common Rare; conjunctivitis may occur with adenovirus Soreness behind eyes, sometimes conjunctivitis
Nasal discharge Common Common Common
Nasal congestion Common Common Sometimes
Sneezing Very common Very common Sometimes
Sore throat Sometimes (postnasal drip); itchy throat Very common Sometimes
Cough Sometimes Common, mild to moderate, hacking cough Common, dry cough, can be severe
Headache Sometimes, facial pain Rare Common
Fever Never Rare in adults, possible in children Very common, 100-102°F or higher (in young children), lasting 3-4 days; may have chills
Malaise Sometimes Sometimes Very common
Fatigue, weakness Sometimes Sometimes Very common, can last for weeks, extreme exhaustion early in course
Myalgias Never Slight Very common, often severe
Duration Weeks 3-14 days 7 days, followed by additional days of cough and fatigue
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.